(Q37689488)

22 August 2017

1 reference

title

Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins (English)

1 reference

22 August 2017

1 reference

1 reference

3

John J P Kastelein

1 reference

22 August 2017

Radjesh J Bisoendial

1

1 reference

22 August 2017

Erik S G Stroes

series ordinal

2

1 reference

22 August 2017

Paul Peter Tak

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

9 February 2010

1 reference

Nature Reviews Rheumatology

22 August 2017

published in

1 reference

22 August 2017

volume

6

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

157-164

1 reference

Preclinical carotid atherosclerosis in patients with rheumatoid arthritis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

The mortality of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Efficacy of statins in familial hypercholesterolaemia: a long term cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Measurement of subclinical atherosclerosis: beyond risk factor assessment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Coronary artery disease is more severe in older persons with rheumatoid arthritis than in older persons without rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

The macrophage: past, present and future

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Macrophage activation and polarization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Erythrocyte Sedimentation Rate, an Independent Predictor of Coronary Heart Disease in Men and Women: The Reykjavik Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Functional subsets of CD4 T cells in rheumatoid synovitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Vessel-specific Toll-like receptor profiles in human medium and large arteries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Inverse association between obesity and antinuclear antibodies in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Leflunomide and hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Assessment of the efficacy of different statins in murine collagen-induced arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Therapy with statins in patients with refractory rheumatic diseases: a preliminary study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Simvastatin improves endothelial function in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Increased Mortality Among Persons with Rheumatoid Arthritis, But Where RA Does Not Appear on Death Certificate:Eleven-Year Follow-Up of an Epidemiological Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Mortality in rheumatoid arthritis patients with disease onset in the 1980s

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Total mortality is increased in rheumatoid arthritis. A 17-year prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.277

Influence of simvastatin on the production of pro-inflammatory cytokines and nitric oxide by activated human chondrocytes

31 March 2020

1 reference

12 December 2020

Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95

1 reference

12 December 2020

Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort.

1 reference

12 December 2020

Effect of intradermal tumor necrosis factor-alpha-induced inflammation on coagulation factors in dermal vessel endothelium. An in vivo study of human skin biopsies

1 reference

12 December 2020

Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: followup after a mean of 13.3 years

1 reference

12 December 2020

Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients.

1 reference

12 December 2020

Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.

1 reference

12 December 2020

Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992

1 reference

12 December 2020

Subclinical coronary artery calcification and relationship to disease duration in women with rheumatoid arthritis

1 reference

12 December 2020

Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.

1 reference

12 December 2020

Mortality trends in rheumatoid arthritis: the role of rheumatoid factor

1 reference

12 December 2020

Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup

1 reference

12 December 2020

Cardiovascular mortality in women with rheumatoid arthritis

1 reference

12 December 2020

Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.

1 reference

12 December 2020

Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2009.277

1 reference

22 August 2017

1 reference